Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: a National Cancer Institute of Canada Clinical Trials Group investigational new drug study (Q40485362)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: a National Cancer Institute of Canada Clinical Trials Group investigational new drug study |
scientific article |
Statements
1 reference
Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: a National Cancer Institute of Canada Clinical Trials Group investigational new drug study (English)
1 reference
Eric Winquist
1 reference
Jennifer Knox
1 reference
Jean-Pierre Ayoub
1 reference
Lori Wood
1 reference
Nancy Wainman
1 reference
Gregory K Reid
1 reference
Laura Pearce
1 reference
Ajit Shah
1 reference
Elizabeth Eisenhauer
1 reference
1 March 2006
1 reference
1 reference
24
1 reference
2
1 reference
159-167
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference